Skip to main content

Abeona Therapeutics Inc.

ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000318306

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Abeona Therapeutics Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of ABEO: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders4133−8
Shares8.17M7.53M−648.2K (−7.9%)
Value$28.5M$21.2M−$7.30M (−25.6%)

New holders (4)

Institutions that held Abeona Therapeutics Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to ABEO in Q1 2023
InstitutionSharesValue% of portfolio
Western Standard LLC224,151$632.1K0.64%
Northern Trust Corp33,696$95.0K0.00%
Charles Schwab Investment Management Inc18,000$50.8K0.00%
25 LLC5$160.00%

Sold out (12)

Institutions that held Abeona Therapeutics Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of ABEO in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Armistice Capital, LLC1,106,000$3.41M
EcoR1 Capital, LLC1,086,956$3.35M
Altium Capital Management LP108,696$334.8K
XTX Topco Ltd51,888$159.8K
Jane Street Group, LLC37,401$115.2K
Dark Forest Capital Management LP2,764$8.51K
Rockefeller Capital Management L.P.1,500$4.00K
UBS Group AG967$2.98K
IFP Advisors, Inc400$2.00K
Money Concepts Capital Corp200$616
Bank of America Corp32$98
Global Retirement Partners, LLC6$18